Summary
Overview
Work History
Education
Skills
Custom
Custom
Timeline
Generic

Keri Roseberry

Leander,TX

Summary

Patient focused team player with over 20 years of sales experience within multiple therapeutic areas and physician specialties. Ethical, clinically focused professional with a specific talent for building strong business relationships with providers and challenging accounts. I am interested in an opportunity at BMS where I can continue to develop productive, long-term relationships and deliver on our commitment to patients.

Overview

25
25
years of professional experience

Work History

SENIOR THERAPEUTIC AREA SPECIALIST

Bristol Myers Squibb Pharmaceuticals, Inc.
09.2019 - Current
  • Hematology: Texas Oncology, Baylor Scott & White Cancer, Cancer Centers throughout Central / North TX
  • Launched Inrebic as part of the crossover sales force during the Celgene transition
  • Assisted DBM with transition by hosting district conference calls to walk through BMS transition processes
  • Maintained strong working relationship with cross functional teammates in Hematology, Oncology, CNC, and VAP organizations to best respond to the needs of customers and accounts in an efficient and timely manner
  • Launched CC-486/Onureg: Promoted Onureg to key accounts in the Austin territory holding virtual calls, virtual lunch appointments, mailing approved resources to customers and utilizing all available resources to make an impact in territory
  • Completed Training and started promoting Reblozyl for MDS
  • Assisted training department with Onureg Crossover Training for Multiple Myeloma team
  • Assisted training department with Sprycel training & workshops
  • Completed training for Multiple Myeloma portfolio, Revlimid, Pomalyst, Empliciti.
  • Increased regional sales by developing and implementing targeted marketing strategies.
  • Conducted in-depth market analysis to identify trends, opportunities, and potential threats, informing key decision-making processes.
  • 2023 Worked with Oncology team to promoted Opdualag
  • 2023 Trained on Breyanzi and began promotion for DLBCL
  • 2023 Trained on Abecma promoted to community physicians to drive referrals to treatment centers.

TERRITORY BUSINESS MANGER IMMUNO-ONCOLOGY

Bristol Myers Squibb Pharmaceuticals, Inc.
01.2018 - 09.2019
  • Responsible for promotion of Opdivo for squamous cell carcinoma of the head and neck (SCCHN) and non-small cell lung cancer NSCLC to medical oncologists in the Austin/San Antonio territory
  • HEME: Promoted Sprycel to the hematology specialists for CML.
  • Analyzed data and reports to identify opportunities in this rare disease hematology market.
  • Served as the Houston District tumor point lead for SCCHN, providing district updates and hosting conference calls as needed to roll out team strategies and relevant marketplace developments
  • Coordinated with 6 person team to develop business plan and manage resources to achieve consistent regional and national leadership position with 4 product portfolio
  • Ranked #2 in South Central Region
  • Established and continue to develop relationships with physicians and other health care providers in the territory to maintain growth trend & regional leadership from a results perspective and also to gain a deep knowledge and understanding of the specialty and the unique patient and provider journey through these difficult diseases.

EXECUTIVE CARDIOVASCULAR SPECIALTY REPRESENTATIVE

Janssen Pharmaceuticals, Inc.
11.2012 - 01.2018
  • Recruited for continued launch and promotion of Xarelto to cardiologists and electrophysiologists in Austin, San Antonio and surrounding areas
  • Worked with multiple overlap partners to coordinate efforts to maximize targeting, reach and messaging strategies with cardiology KOL's
  • Secondary focus on hematology/oncology customers, hospitalists, emergency and critical care physicians
  • Successfully developed and maintained relationships with influential cardiologists and electrophysiologists in a highly competitive NOAC market
  • Managed speaker program placement, coordination and execution for 6 local KOL's
  • Special Project: Organized and planed strategic collaboration with Austin Heart Hospital administration to align EMR system with benefits investigation/managed care resources to identify appropriate patients for medication compliance and therapy evaluations
  • Achieved consistent leadership in total volume sales, new to brand growth and market share leadership for 5 consecutive years
  • Three-time winner of the Janssen Team Award 2013, 2014, 2015
  • Top 5% market share and market volume nationally.

CARDIOLOGY SPECIALTY REPRESENTATIVE

Boehringer Ingelheim Pharmaceuticals, Inc.
10.2009 - 11.2012
  • Focused on training and market prep for Pradaxa, the first new oral anticoagulant to come to market in 50 years
  • Development of launch strategy and analysis including territory business plan, 180-day strategic routing and tactical implementation plan
  • Launched Pradaxa and achieved 16% market share within 6 months of launch, and 900% goal attainment, generating $6.2M in sales for 2011
  • Ranked #1 in the nation for product volume sales, market share and market share growth during critical launch phase
  • Intense collaboration with hospital specialist and primary care sales division to drive education and formulary uptake in key accounts
  • Pradaxa was approved & on formulary in all local accounts on launch date
  • Serve as Field Intelligence/Strategic Liaison for senior leadership team and counterparts nationally.

CARDIO/PULMONARY SPECIALTY REPRESENTATIVE

Boehringer Ingelheim Pharmaceuticals, Inc.
10.2008 - 10.2009
  • Responsible for promotion and sales of the organization's top promoted brands to cardiologists, pulmonologists, nephrologists within the Austin and San Antonio markets
  • Demonstrated ability to expand market and grow business, climbing in rankings from #23 to #12 over 12 months
  • Appointed by RBD to facilitate regional training for experienced representatives post re-alignment.

NEUROLOGY HOSPITAL SALES SPECIALIST

Boehringer Ingelheim Pharmaceuticals, Inc.
01.2006 - 10.2008
  • Recruited to establish newly formed Neurology Specialty Sales Division for launch of Aggrenox and Mirapex in hybrid role with office based and hospital sales responsibility
  • Successful promotion of antiplatelet for stroke prevention and dopamine agonist for Parkinson's and RLS
  • Closed out 2008 ranked #1 for Mirapex and #2 for Aggrenox nationally
  • Established a monthly neurology journal club with stoke team and neurology residents in a major hospital account.

PROFESSIONAL SALES REPRESENTATIVE

Boehringer Ingelheim Pharmaceuticals, Inc.
08.1999 - 12.2005
  • Completed extensive sales, product knowledge and industry specific training including management development and targeted selection
  • Responsible for promotion and growth of brands related to respiratory, cardiovascular, orthopedic and cerebrovascular medications to all related specialists
  • Demonstrated ability to grow business through productive, long-term relationships resulting in consistent territory growth
  • Moved territory from last in the region when hired to #3 in 18 months.

Education

Skills

● Effective Communication

● Team Leadership & Development

● Strategic Business Planning

● Patient Focused Approach

● Problem-Solving

● Relationship Building

● Cross-Functional Team Collaboration

● Product Launch Expertise

Custom

  • Onureg 2020
  • Inrebic (fedratinib) 2019
  • Xarelto (rivaroxaban)-anticoagulant 2012
  • Pradaxa (dabigatran)-anticoagulant 2010
  • Mirapex (pramipexole)-dopamine agonist 2007
  • Aggrenox (aspirin and dipyridamole)-antiplatelet 2006
  • Spiriva (tiotropium bromide)-bronchodilator 2004
  • Mobic (meloxicam)-nonsteroidal anti-inflammatory 2000

Custom

  • 2017 Platinum RBD Encore Award
  • 2016-17 Appointed to Regional Executive Council
  • 2016 Never Settle Contest Winner for NBRx growth
  • 2013-15 Janssen Team Award
  • 2012 National Market Share leader (>2 times national average)
  • 2011 BI President's Club Winner
  • 2011 Platinum Award Winner for launch excellence
  • 2011 Building the Base Contest Winner
  • 2010-11 #1 in the nation for product volume, MS & MS growth
  • 2011 3 time winner of the REACH award for leadership
  • 2008 #1 National MS for Mirapex
  • 2008 #2 National MS for Aggrenox

Timeline

SENIOR THERAPEUTIC AREA SPECIALIST

Bristol Myers Squibb Pharmaceuticals, Inc.
09.2019 - Current

TERRITORY BUSINESS MANGER IMMUNO-ONCOLOGY

Bristol Myers Squibb Pharmaceuticals, Inc.
01.2018 - 09.2019

EXECUTIVE CARDIOVASCULAR SPECIALTY REPRESENTATIVE

Janssen Pharmaceuticals, Inc.
11.2012 - 01.2018

CARDIOLOGY SPECIALTY REPRESENTATIVE

Boehringer Ingelheim Pharmaceuticals, Inc.
10.2009 - 11.2012

CARDIO/PULMONARY SPECIALTY REPRESENTATIVE

Boehringer Ingelheim Pharmaceuticals, Inc.
10.2008 - 10.2009

NEUROLOGY HOSPITAL SALES SPECIALIST

Boehringer Ingelheim Pharmaceuticals, Inc.
01.2006 - 10.2008

PROFESSIONAL SALES REPRESENTATIVE

Boehringer Ingelheim Pharmaceuticals, Inc.
08.1999 - 12.2005

Similar Profiles

CREATE PROFILE
Keri Roseberry